Filana Therapeutics Inc (FLNA)

[WebSlinger]

***Seeking Alpha article: Cassava Sciences' Simufilam Could Be Approved Before The End Of 2022***

Here is a quote from the article:

"Just like Moderna was trading a year ago at $20 per share and there were law firms chasing them for misleading claims, I believe that Cassava Sciences two years from now could be trading for over $700 per share upon approval."

https://seekingalpha.com/article/4457665-cassava-sciences-simuliflam-could-be-approved